| Prevalence and impact of diabetes among people infected with SARS-CoV-2 GP Fadini, ML Morieri, E Longato, A Avogaro Journal of endocrinological investigation 43 (6), 867-869, 2020 | 430 | 2020 |
| Exposure to dipeptidyl‐peptidase‐4 inhibitors and COVID‐19 among people with type 2 diabetes: A case‐control study GP Fadini, ML Morieri, E Longato, BM Bonora, S Pinelli, E Selmin, ... Diabetes, Obesity and Metabolism 22 (10), 1946-1950, 2020 | 83 | 2020 |
| Cardiovascular outcomes of type 2 diabetic patients treated with SGLT-2 inhibitors versus GLP-1 receptor agonists in real-life E Longato, B Di Camillo, G Sparacino, L Gubian, A Avogaro, GP Fadini BMJ Open Diabetes Research and Care 8 (1), e001451, 2020 | 36 | 2020 |
| Diabetes diagnosis from administrative claims and estimation of the true prevalence of diabetes among 4.2 million individuals of the Veneto region (North East Italy) E Longato, B Di Camillo, G Sparacino, C Saccavini, A Avogaro, GP Fadini Nutrition, Metabolism and Cardiovascular Diseases 30 (1), 84-91, 2020 | 36 | 2020 |
| A practical perspective on the concordance index for the evaluation and selection of prognostic time-to-event models E Longato, M Vettoretti, B Di Camillo Journal of Biomedical Informatics 108, 103496, 2020 | 24 | 2020 |
| Better cardiovascular outcomes of type 2 diabetic patients treated with GLP-1 receptor agonists versus DPP-4 inhibitors in clinical practice E Longato, B Di Camillo, G Sparacino, L Tramontan, A Avogaro, ... Cardiovascular diabetology 19 (1), 1-12, 2020 | 22 | 2020 |
| Simple linear support vector machine classifier can distinguish impaired glucose tolerance versus type 2 diabetes using a reduced set of CGM-based glycemic variability indices E Longato, G Acciaroli, A Facchinetti, A Maran, G Sparacino Journal of diabetes science and technology 14 (2), 297-302, 2020 | 12 | 2020 |
| HAPT2D: high accuracy of prediction of T2D with a model combining basic and advanced data depending on availability B Di Camillo, L Hakaste, F Sambo, R Gabriel, J Kravic, B Isomaa, ... European journal of endocrinology 178 (4), 331-341, 2018 | 12 | 2018 |
| Glycaemic variability-based classification of impaired glucose tolerance vs. type 2 diabetes using continuous glucose monitoring data E Longato, G Acciaroli, A Facchinetti, L Hakaste, T Tuomi, A Maran, ... Computers in biology and medicine 96, 141-146, 2018 | 11 | 2018 |
| A deep learning approach to predict diabetes’ cardiovascular complications from administrative claims E Longato, GP Fadini, G Sparacino, A Avogaro, L Tramontan, ... IEEE Journal of Biomedical and Health Informatics 25 (9), 3608-3617, 2021 | 8 | 2021 |
| Cardiovascular effectiveness of human-based vs. exendin-based glucagon like peptide-1 receptor agonists: a retrospective study in patients with type 2 diabetes E Longato, B Di Camillo, G Sparacino, L Tramontan, A Avogaro, ... European Journal of Preventive Cardiology 28 (1), 22-29, 2021 | 7 | 2021 |
| Exposure to dipeptidyl‐peptidase 4 inhibitors and the risk of pneumonia among people with type 2 diabetes: retrospective cohort study and meta‐analysis ML Morieri, BM Bonora, E Longato, B Di Camilo, G Sparacino, ... Diabetes, Obesity and Metabolism 22 (10), 1925-1934, 2020 | 7 | 2020 |
| Improved long-term cardiovascular outcomes after intensive versus standard screening of diabetic complications: an observational study ML Morieri, E Longato, M Mazzucato, B Di Camillo, A Cocchiglia, ... Cardiovascular diabetology 18 (1), 1-9, 2019 | 7 | 2019 |
| Expected accuracy of proximal and distal temperature estimated by wireless sensors, in relation to their number and position on the skin E Longato, M Garrido, D Saccardo, C Montesinos Guevara, AR Mani, ... PloS one 12 (6), e0180315, 2017 | 7 | 2017 |
| Outcomes of patients with type 2 diabetes treated with SGLT-2 inhibitors versus DPP-4 inhibitors. An Italian real-world study in the context of other observational studies E Longato, BM Bonora, B Di Camillo, G Sparacino, L Tramontan, ... Diabetes Research and Clinical Practice 179, 109024, 2021 | 3 | 2021 |
| Prediction of cardiovascular complications in diabetes from pharmacy administrative claims E Longato, GP Fadini, G Sparacino, L Gubian, B Di Camillo 2020 IEEE 20th Mediterranean Electrotechnical Conference (MELECON), 315-320, 2020 | 3 | 2020 |
| Importance of recalibrating models for type 2 diabetes onset prediction: application of the Diabetes Population Risk Tool on the health and retirement study M Vettoretti, E Longato, B Di Camillo, A Facchinetti 2018 40th Annual International Conference of the IEEE Engineering in …, 2018 | 3 | 2018 |
| Addressing practical issues of predictive models translation into everyday practice and public health management: a combined model to predict the risk of type 2 diabetes … M Vettoretti, E Longato, A Zandonà, Y Li, JA Pagán, D Siscovick, ... BMJ Open Diabetes Research and Care 8 (1), e001223, 2020 | 2 | 2020 |
| Comparing the Predictive Power of Heart Failure Hospitalisation Risk Scores in the Diabetic Outpatient Clinic and Primary Care Settings A Guazzo, A Battaggia, E Longato, B Franco-Novelletto, A Avogaro, ... 2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM …, 2021 | 1 | 2021 |
| Ranking Physiological, Lifestyle and Environmental Risk Factors for Predicting Type 2 Diabetes Onset A Zandona, M Vettoretti, E Longato, Y Li, K Madondo, J Pagan, ... DIABETES TECHNOLOGY & THERAPEUTICS 21, A90-A90, 2019 | 1 | 2019 |
